Literature DB >> 2465290

Neurogenic plasma extravasation: inhibition by morphine in guinea pig airways in vivo.

M G Belvisi1, D F Rogers, P J Barnes.   

Abstract

Opioid drugs have been shown to inhibit neurogenic plasma exudation in skin by a presynaptic mechanism. We determined whether a similar inhibitory effect operates in the airways of anesthetized guinea pigs in vivo with the use of Evans blue dye as a marker of plasma leakage. Stimulation of the vagus nerve significantly increased leakage of dye in trachea and main bronchi (by approximately 300 and 600%, respectively). Similar increases in leakage were seen in the presence of atropine and propranolol. Morphine (1-30 mg/kg iv) inhibited leakage in a dose-related manner with complete inhibition in the trachea at a dose of 30 mg/kg. The inhibition was blocked by the opioid receptor-antagonist naloxone (1 mg/kg iv). Intravenous substance P significantly increased leakage but was not inhibited by morphine. We conclude that morphine inhibits neurogenic plasma leakage by presynaptic inhibition of release of neuropeptides from sensory nerve endings. If similar mechanisms are operative in human airways, inhibition of neurogenic plasma leakage by opioid drugs devoid of central effects may be of value in the therapy of asthma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2465290     DOI: 10.1152/jappl.1989.66.1.268

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  13 in total

1.  Bradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factor.

Authors:  D F Rogers; S Dijk; P J Barnes
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

2.  Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.

Authors:  K E Pedersen; P J Rigby; R G Goldie
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

3.  Does nebulized fentanyl relieve dyspnea during exercise in healthy man?

Authors:  Houssam G Kotrach; Jean Bourbeau; Dennis Jensen
Journal:  J Appl Physiol (1985)       Date:  2015-03-12

4.  Hyperbaric oxygen increases plasma exudation in rat trachea: involvement of nitric oxide.

Authors:  M Bernareggi; S Radice; G Rossoni; G Oriani; E Chiesara; F Berti
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro.

Authors:  N J Ray; A J Jones; P Keen
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

6.  Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig.

Authors:  C Advenier; Y Qian; J D Koune; M Molimard; M L Candenas; E Naline
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

7.  Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways.

Authors:  M G Belvisi; H J Patel; V Freund-Michel; D J Hele; N Crispino; M A Birrell
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

8.  Differential inhibitory effects of opioids on cigarette smoke, capsaicin and electrically-induced goblet cell secretion in guinea-pig trachea.

Authors:  H P Kuo; J A Rohde; P J Barnes; D F Rogers
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

9.  Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD.

Authors:  Mark A Birrell; Natascia Crispino; David J Hele; Hema J Patel; Magdi H Yacoub; Peter J Barnes; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

10.  Attenuation of tachykinin-induced airflow obstruction and microvascular leakage in immature airways.

Authors:  K Tokuyama; T Yokoyama; A Morikawa; H Mochizuki; T Kuroume; P J Barnes
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.